David Lin is the Co-founder and Chief Scientific Officer at Bristle. David received his PhD in Microbiology and Immunology from the University of Michigan, Ann Arbor. He has over 10 years of molecular biology, microbiology, genomics, and synthetic biology experience across academia, public health, and industry. He has an extensive background in infectious disease and genomics, which is highlighted by his 11 peer-reviewed publications, with 6 as first author.